FDA Inspection
Emerson HospitalEmerson Hospital – FDA Inspection, Jul 19, 2010
Record Details
This FDA Inspection record concerns Emerson Hospital, with an inspection on July 19, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Emerson Hospital
- Inspection Date
- July 19, 2010
- Product Type
- Biologics
View Company Profile
ID · d18f58c0-bd4f-42b5-81c8-544929ffbbd5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 672251
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.170(a)Adverse Reaction - Investigations
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Emerson Hospital
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2025 | VAI | New England District Office | Blood and Blood Products |
| March 30, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 4, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 13, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Emerson Hospital
- FDA Inspection 1277644 - 2025-08-06
- FDA Inspection 1202980 - 2023-03-30
- FDA Inspection 1078912 - 2019-02-04
- FDA Inspection 1010013 - 2017-04-13
- FDA Inspection 916284 - 2015-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.